Subscribe
Date
Past
2015
2016
2017
2018
2019
2020
2021
Upcoming

Kevin Tyo, PhD, and Kevin Grady, BS, are adept at developing cell-based assays that incorporate immortalized primary cells. Join this webinar to hear Dr. Tyo and Mr. Grady cover these topics:

  • hTERT-immortalized primary cells are comparable to primary cells regarding physiological relevance, but are able to avoid replicative senescence.
  • Using well-characterized hTERT-immortalized cells, ATCC has created credible cell models for toxicological studies on the kidney, skin, and airway.
  • Our data show that these modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.